Back to School: How biopharma can reboot drug development. Access exclusive analysis here

CellSearch Circulating Tumor Cell Kit: 510 (k) submitted

IMMC submitted a 510(k) application to FDA for CellSearch Circulating

Read the full 107 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE